Centre Hospitalier Universitaire De Caen Normandie — Sponsor Intelligence | 8 EU Trials

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

5 Recruiting

0 Completed trials

1 Countries active

14 Unique IMPs

N/A Results reported

Phase III

Phase II/III

Phase II

Phase IV

Phase III: 3 Phase II/III: 2 Phase II: 2 Phase IV: 1

Oversight events:

1 urgent safety measure across 1 trial

View oversight register →

Top indications

Chronic coronary syndrome 1 Palliative care 1

Top IMPs

D,L-LYSINE ACETYLSALICYLATE 2 ACETYLSALICYLIC ACID 1 CLOPIDOGREL 1 LAMIVUDINE, DORAVIRINE, TENOFOVIR DISOPROXIL 1 MICRONISED SPIRONOLACTONE 1 PARACETAMOL 1 PRASUGREL 1 PREDNISONE 1 ROCURONIUM BROMIDE 1 SUGAMMADEX 1 TICAGRELOR 1

All trials

8 total

SPironolactONe for the maintenance of Sinus Rhythm in hypertensive patients with atrial fibrillation and preserved left ventricular ejection… Pending

2024-518146-25-00 Phase III 1 country MICRONISED SPIRONOLACTONE
RANDOMIZED, CONTROLLED, OPEN TRIAL OF TWO STANDARDIZED DECLINE SCHEMES, FAST (NORTH AMERICAN) AND SLOW (EUROPEAN) RESPECTIVELY, OF CORTISONE… Pending

2024-518653-41-00 Phase III 1 country PREDNISONE
Pilot study of the pharmacokinetic profile of subcutaneous versus intravenous paracetamol in palliative patients Pending

2024-518795-31-00 Phase II/III 1 country PARACETAMOL
A DOSE-DETERMINATION STUDY OF SUGAMMADEX AS A ROCURONIUM DECURARIZATION AGENT IN CHILDREN UNDER 2 YEARS OF AGE Recruiting

2025-521946-82-00 Phase II 1 country ROCURONIUM BROMIDE; SUGAMMADEX
Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneou… Recruiting

2023-507545-28-00 Phase IV 1 country CLOPIDOGREL; D,L-LYSINE ACETYLSALICYLATE; PRASUGREL; TICAGRELOR
Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non valvular atrial fibrillation: a randomized controll… Recruiting

2023-507544-37-00 Phase III 1 country
Short versus long antiplatelet therapy after TAVI Recruiting

2023-508208-40-00 Phase II/III 1 country ACETYLSALICYLIC ACID; D,L-LYSINE ACETYLSALICYLATE
Efficacy of the Doravirine/Tenofovir Disoproxil Fumarate/Lamivudine combination in people living with HIV with a history of M184V/I mutation… Recruiting

2023-505845-17-00 Phase II 1 country LAMIVUDINE, DORAVIRINE, TENOFOVIR DISOPROXIL

Showing 1–8 of 8 trials

← All sponsors A–Z